Generate Biomedicines Stock

Generate Biomedicines is a biotechnological company focusing on creating breakthrough medicines.

Sign up today and learn more about Generate Biomedicines Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Generate Biomedicines Stock

Generate Biomedicines is a biotechnological company focusing on creating breakthrough medicines. It pioneers in the field of Generative Biology, a revolutionary approach to drug development that allows them to program protein-based modalities for the first time.

Funding History

September 2020$50.0M
November 2021$370M
September 2023$273M

Management

Chief Scientific Officer

Michael Nohaile

Co-Founder

Sophie de Boer

Chief Digital Officer

Dimitris Agrafiotis

Senior Vice President Technical Operations

Lisa Wyman

Co-Founder,CEO and Board member

Geoffrey von Maltzahn

Chairman and Co-Founder

Noubar Afeyan

Head of Infectious Disease and Vaccines Research

Daria Hazuda

Co-Founder and Chief Innovation Officer

Molly Gibson

Board of Director

Noubar Afeyan

Chief Legal Officer and General Counsel

Sean Martin

CEO

Michael Nally

Co-Founder and Chief Technology Officer

Gevorg Grigoryan

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo